@xconomy.com 2 months ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com 11 months ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com 1 year ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@tech.eu 1 year ago
Kheiron’s $22 million Series A funds early breast cancer detection for women worldwide
@xconomy.com 1 year ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More